Results 41 to 50 of about 600,868 (344)

Hepatocellular carcinoma: Review of disease and tumor biomarkers. [PDF]

, 2016
© The Author(s) 2016.Hepatocellular carcinoma (HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative
Cox, IJ, Crossey, MM, Fye, HK, Gomez-Romero, M, Holmes, E, Kim, JU, Njie, R, Shariff, MI, Taylor-Robinson, SD   +8 more
core   +1 more source

Hepatocellular Carcinoma Segmentation from Digital Subtraction Angiography Videos using Learnable Temporal Difference [PDF]

arXiv, 2021
Automatic segmentation of hepatocellular carcinoma (HCC) in Digital Subtraction Angiography (DSA) videos can assist radiologists in efficient diagnosis of HCC and accurate evaluation of tumors in clinical practice. Few studies have investigated HCC segmentation from DSA videos.
arxiv  

Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement [PDF]

, 2015
Hepatocellular carcinoma (HCC) is the most common malignancy of the liver and the third cause of cancer death worldwide. Chronic hepatitis due to HBV and HCV infection are two major risk factors for HCC worldwide.
Cuestas, María Luján, Mathet, Veronica Lidia, Oubiña, Jose Raul   +2 more
core   +1 more source

Multicategory Matched Learning for Estimating Optimal Individualized Treatment Rules in Observational Studies with Application to a Hepatocellular Carcinoma Study [PDF]

arXiv, 2023
One primary goal of precision medicine is to estimate the individualized treatment rules (ITRs) that optimize patients' health outcomes based on individual characteristics. Health studies with multiple treatments are commonly seen in practice. However, most existing ITR estimation methods were developed for the studies with binary treatments.
arxiv  

Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma [PDF]

, 2016
BACKGROUND: Prognostic assessment in patients with hepatocellular carcinoma (HCC) remains controversial. Using the Italian Liver Cancer (ITA.LI.CA) database as a training set, we sought to develop and validate a new prognostic system for patients with ...
Benvegnu', Luisa, Biasini, Elisabetta, Borzio, Franco, Cabibbo, Giuseppe, Caturelli, Eugenio, Ciccarese, Francesca, Cillo, Umberto, Di Marco, Mariella, Farinati, Fabio, Felder, Martina, Foschi, Francesco Giuseppe, Frigo, Anna Chiara, Gasbarrini, Antonio, Giacomin, Anna, Giannini, Edoardo G., Huo, Teh La, Lee, Yun Hsuan, Masotto, Alberto, Morisco, Filomena, Pawlik, Timothy M., Piscaglia, Fabio, Rapaccini, Gian Lodovico, Sacco, Rodolfo, Spolverato, Gaya, Svegliati Baroni, Gianluca, Trevisani, Franco, Virdone, Roberto, Vitale, Alessandro, Zoli, Marco   +28 more
core   +4 more sources

Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective

Technology in Cancer Research & Treatment, 2020
Background and Objectives: Although cholangiolocellular carcinoma is considered a combined hepatocellular and cholangiocarcinoma, we feel that this classification is not appropriate.
Hiroyuki Takamura PhD, MD, Ryousuke Gabata MD, Yoshinao Obatake PhD, MD, Shinichi Nakanuma PhD, MD, Hironori Hayashi PhD, MD, Kazuto Kozaka PhD, MD, Motoko Sasaki PhD, MD, Mitsuyoshi Okazaki PhD, MD, Takahisa Yamaguchi PhD, MD, Hiroyuki Shimbashi PhD, MD, Shiro Terai PhD, MD, Koichi Okamoto PhD, MD, Isamu Makino PhD, MD, Jun Kinoshita PhD, MD, Keishi Nakamura PhD, MD, Tomoharu Miyashita PhD, MD, Hidehiro Tajima PhD, MD, Itasu Ninomiya PhD, MD, Sachio Fushida PhD, MD, Azusa Kitao PhD, MD, Masaaki Kitahara PhD, MD, Kuniaki Arai PhD, MD, Taro Yamashita PhD, MD, Tatsuya Yamashita PhD, MD, Hiroko Ikeda PhD, MD, Yasunori Satoh PhD, MD, Kenichi Harada PhD, MD, Syuichi Kaneko PhD, MD, Toshihumi Gabata PhD, MD, Tateo Kosaka PhD, MD, Tetsuo Ohta PhD, MD   +30 more
doaj   +1 more source

A Hierarchical Transformer Encoder to Improve Entire Neoplasm Segmentation on Whole Slide Image of Hepatocellular Carcinoma [PDF]

arXiv, 2023
In digital histopathology, entire neoplasm segmentation on Whole Slide Image (WSI) of Hepatocellular Carcinoma (HCC) plays an important role, especially as a preprocessing filter to automatically exclude healthy tissue, in histological molecular correlations mining and other downstream histopathological tasks.
arxiv  

Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma. [PDF]

, 2018
Hepatocellular carcinoma (HCC), is one of the most frequent human cancer and is characterized by a high mortality rate. The aggressiveness appears strictly related to the liver pathological background on which cancer develops.
Amicone, Laura, Marchetti, Alessandra
core   +1 more source

Inflammatory markers as prognostic factors of survival in patients affected by hepatocellular carcinoma undergoing transarterial chemoembolization [PDF]

, 2017
Transarterial chemoembolization (TACE) is a good choice for hepatocellular carcinoma (HCC) treatment when surgery and liver transplantation are not feasible.
Brunese, L., De Angelis, V., Donini, A., Graziosi, L., Maiettini, D., Marino, E., Metro, G., Mosca, S., Orgera, G., Rebonato, A., Rossi, M., Scialpi, M.   +11 more
core   +3 more sources

COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL

ABCD: Arquivos Brasileiros de Cirurgia Digestiva, 2016
Background: Liver transplantation is the usual treatment for hepatocellular carcinoma. Aim : To analyze the MELD score, waiting time and three month and one year survival for liver transplantation in cirrhotic patients affected by hepatocellular ...
Alexandre Coutinho Teixeira de FREITAS, Rafael Shinmi SHIGUIHARA, Ruan Teles MONTEIRO, Thiago Linck PAZETO, Júlio Cezar Uili COELHO   +4 more
doaj   +2 more sources